Not logged in Share Save
Share Save
Share Save
Dapagliflozin enhances arterial and venous compliance during exercise in heart failure with preserved ejection fraction Tada, A.; Burkhoff, D.; Naser, J.; Harada, T.; Pourmussa, B.; Reddy, Y.; Jensen, M.; Carter, R.; Testani, J.; Chirinos, J.; Borlaug, B. Share Save
Dapagliflozin Enhances Arterial and Venous Compliance During Exercise in Heart Failure With Preserved Ejection Fraction: Insights From the CAMEO-DAPA Trial Tada, Atsushi; Burkhoff, Daniel; Naser, Jwan A.; Harada, Tomonari; Pourmussa, Bianca; Reddy, Yogesh N. V.; Jensen, Michael D.; Carter, Rickey E.; Demmer, Ryan T.; Testani, Jeffrey M.; Chirinos, Julio A.; Borlaug, Barry A. Share Save
Share Save
Dapagliflozin, peptide YY, and weight loss in heart failure with preserved ejection fraction Reddy, Yogesh N., V; Melenovsky, Vojtech; Asokan, Aneesh K.; Haluzik, Martin; Carter, Rickey E.; Nair, Sreekumaran; Jensen, Michael D.; Borlaug, Barry A. Share Save
Share Save
Similar insulin regulation of splanchnic FFA and VLDL-TG in men with nonalcoholic hepatic steatosis and steatohepatitis Risikesan, Jeyanthini; Heeboll, Sara; Kumarathas, Indumathi; Sondergaard, Esben; Johansen, Rakel F.; Ringgaard, Steffen; Aagaard, Niels K.; Sandahl, Thomas D.; Villadsen, Gerda E.; Gormsen, Lars C.; Frystyk, Jan; Jensen, Michael D.; Gronbaek, Henning; Nielsen, Soren Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save